{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:48:09Z","timestamp":1782776889977,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Austrian FWF , 7th Framework Program of the European Union (integrated projects AtheroRemo, RiskyCAD, the German Federal Ministry of Education and Research,"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-026-02973-8","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:25:08Z","timestamp":1778124308000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Associations of ANGPTL3\/4\/8 proteins and complexes with heart failure and heart failure mortality"],"prefix":"10.1186","volume":"25","author":[{"given":"G\u00fcnther","family":"Silbernagel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Cathrin","family":"Maas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deven","family":"Lemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Q.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene Y.","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus E.","family":"Kleber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela P.","family":"Moissl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"M\u00e4rz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Niessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Scharnagl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Konrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"2973_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/eurjpc\/zwac290","volume":"30","author":"J Xiao","year":"2023","unstructured":"Xiao J, Ji J, Zhang N, et al. Association of genetically predicted lipid traits and lipid-modifying targets with heart failure. Eur J Prev Cardiol. 2023;30:358\u201366.","journal-title":"Eur J Prev Cardiol"},{"key":"2973_CR2","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk GD, Karwi QG, Tian R, et al. Cardiac energy metabolism in heart failure. Circ Res. 2021;128:1487\u2013513.","journal-title":"Circ Res"},{"key":"2973_CR3","doi-asserted-by":"publisher","first-page":"E1339","DOI":"10.1152\/ajpendo.00349.2013","volume":"305","author":"RS Khan","year":"2013","unstructured":"Khan RS, Lin Y, Hu Y, et al. Rescue of heart lipoprotein lipase-knockout mice confirms a role for triglyceride in optimal heart metabolism and function. Am J Physiol Endocrinol Metab. 2013;305:E1339\u201347.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2973_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/ng1984","volume":"39","author":"S Romeo","year":"2007","unstructured":"Romeo S, Pennacchio LA, Fu Y, et al. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet. 2007;39:513\u20136.","journal-title":"Nat Genet"},{"key":"2973_CR5","first-page":"70","volume":"119","author":"S Romeo","year":"2009","unstructured":"Romeo S, Yin W, Kozlitina J, et al. Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J Clin Invest. 2009;119:70\u20139.","journal-title":"J Clin Invest"},{"key":"2973_CR6","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1056\/NEJMoa1510926","volume":"374","author":"FE Dewey","year":"2016","unstructured":"Dewey FE, Gusarova V, O\u2019Dushlaine C, et al. Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease. N Engl J Med. 2016;374:1123\u201333.","journal-title":"N Engl J Med"},{"key":"2973_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1612790","volume":"377","author":"FE Dewey","year":"2017","unstructured":"Dewey FE, Gusarova V, Dunbar RL, et al. Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease. N Engl J Med. 2017;377:211\u201321.","journal-title":"N Engl J Med"},{"key":"2973_CR8","doi-asserted-by":"publisher","first-page":"19751","DOI":"10.1073\/pnas.1217552109","volume":"109","author":"F Quagliarini","year":"2012","unstructured":"Quagliarini F, Wang Y, Kozlitina J, et al. Atypical angiopoietin-like protein that regulates ANGPTL3. Proc Natl Acad Sci U S A. 2012;109:19751\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2973_CR9","doi-asserted-by":"publisher","first-page":"16109","DOI":"10.1073\/pnas.1315292110","volume":"110","author":"Y Wang","year":"2013","unstructured":"Wang Y, Quagliarini F, Gusarova V, et al. Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc Natl Acad Sci U S A. 2013;110:16109\u201314.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2973_CR10","doi-asserted-by":"crossref","unstructured":"Gusarova V, Banfi S, Alexa-Braun CA et al. (2017) ANGPTL8 blockade with a monoclonal antibody promotes triglyceride clearance, energy expenditure, and weight loss in mice. Endocrinology. 2017;158:1252\u20131259.","DOI":"10.1210\/en.2016-1894"},{"key":"2973_CR11","doi-asserted-by":"publisher","first-page":"E1249","DOI":"10.1073\/pnas.1717420115","volume":"115","author":"S Banfi","year":"2018","unstructured":"Banfi S, Gusarova V, Gromada J, et al. Increased thermogenesis by a noncanonical pathway in ANGPTL3\/8-deficient mice. Proc Natl Acad Sci U S A. 2018;115:E1249\u201358.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2973_CR12","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1194\/jlr.RA120000781","volume":"61","author":"YQ Chen","year":"2020","unstructured":"Chen YQ, Pottanat TG, Siegel RW, et al. Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids. J Lipid Res. 2020;61:1203\u201320.","journal-title":"J Lipid Res"},{"key":"2973_CR13","doi-asserted-by":"publisher","first-page":"e138777","DOI":"10.1172\/jci.insight.138777","volume":"5","author":"F Oldoni","year":"2020","unstructured":"Oldoni F, Cheng H, Banfi S, et al. ANGPTL8 has both endocrine and autocrine effects on substrate utilization. JCI Insight. 2020;5:e138777.","journal-title":"JCI Insight"},{"key":"2973_CR14","doi-asserted-by":"publisher","first-page":"101140","DOI":"10.1016\/j.plipres.2021.101140","volume":"85","author":"R Zhang","year":"2022","unstructured":"Zhang R, Zhang K. An updated ANGPTL3-4-8 model as a mechanism of triglyceride partitioning between fat and oxidative tissues. Prog Lipid Res. 2022;85:101140.","journal-title":"Prog Lipid Res"},{"key":"2973_CR15","doi-asserted-by":"publisher","first-page":"e2200093","DOI":"10.1002\/adbi.202200093","volume":"6","author":"Y Wen","year":"2022","unstructured":"Wen Y, Chen YQ, Konrad RJ. The regulation of triacylglycerol metabolism and lipoprotein lipase activity. Adv Biol. 2022;6:e2200093.","journal-title":"Adv Biol"},{"key":"2973_CR16","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.tem.2024.02.016","volume":"35","author":"R Zhang","year":"2024","unstructured":"Zhang R, Zhang K. A unified model for regulating lipoprotein lipase activity. Trends Endocrinol Metab. 2024;35:490\u2013504.","journal-title":"Trends Endocrinol Metab"},{"key":"2973_CR17","doi-asserted-by":"publisher","first-page":"100068","DOI":"10.1016\/j.jlr.2021.100068","volume":"62","author":"YQ Chen","year":"2021","unstructured":"Chen YQ, Pottanat TG, Zhen EY, et al. ApoA5 lowers triglyceride levels via suppression of ANGPTL3\/8-mediated LPL inhibition. J Lipid Res. 2021;62:100068.","journal-title":"J Lipid Res"},{"key":"2973_CR18","doi-asserted-by":"publisher","first-page":"e172600","DOI":"10.1172\/JCI172600","volume":"133","author":"Y Yang","year":"2023","unstructured":"Yang Y, Beigneux AP, Song W, et al. Hypertriglyceridemia in Apoa5-\/- mice results from reduced amounts of lipoprotein lipase in the capillary lumen. J Clin Invest. 2023;133:e172600.","journal-title":"J Clin Invest"},{"key":"2973_CR19","doi-asserted-by":"publisher","first-page":"e2322332121","DOI":"10.1073\/pnas.2322332121","volume":"121","author":"YQ Chen","year":"2024","unstructured":"Chen YQ, Yang Y, Zhen EY, et al. Carboxyl-terminal sequences in APOA5 are important for suppressing ANGPTL3\/8 activity. Proc Natl Acad Sci U S A. 2024;121:e2322332121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2973_CR20","doi-asserted-by":"publisher","first-page":"e2528664123","DOI":"10.1073\/pnas.2528664123","volume":"123","author":"Y Yang","year":"2026","unstructured":"Yang Y, Beigneux AP, Lowe TL, et al. A neutralizing APOA5 monoclonal antibody reduces amounts of lipoprotein lipase in capillaries and triggers hypertriglyceridemia. Proc Natl Acad Sci U S A. 2026;123:e2528664123.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2973_CR21","doi-asserted-by":"publisher","first-page":"28488","DOI":"10.1074\/jbc.M004029200","volume":"275","author":"S Kersten","year":"2000","unstructured":"Kersten S, Mandard S, Tan NS, et al. Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J Biol Chem. 2000;275:28488\u201393.","journal-title":"J Biol Chem"},{"key":"2973_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.tem.2013.12.005","volume":"25","author":"W Dijk","year":"2014","unstructured":"Dijk W, Kersten S. Regulation of lipoprotein lipase by Angptl4. Trends Endocrinol Metab. 2014;25:146\u201355.","journal-title":"Trends Endocrinol Metab"},{"key":"2973_CR23","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1194\/jlr.M067363","volume":"57","author":"W Dijk","year":"2016","unstructured":"Dijk W, Beigneux AP, Larsson M, et al. Angiopoietin-like 4 promotes intracellular degradation of lipoprotein lipase in adipocytes. J Lipid Res. 2016;57:1670\u201383.","journal-title":"J Lipid Res"},{"key":"2973_CR24","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jacl.2018.02.006","volume":"12","author":"W Dijk","year":"2018","unstructured":"Dijk W, Schutte S, Aarts EO, et al. Regulation of angiopoietin-like 4 and lipoprotein lipase in human adipose tissue. J Clin Lipidol. 2018;12:773\u201383.","journal-title":"J Clin Lipidol"},{"key":"2973_CR25","doi-asserted-by":"publisher","first-page":"101033","DOI":"10.1016\/j.molmet.2020.101033","volume":"40","author":"PMM Ruppert","year":"2020","unstructured":"Ruppert PMM, Michielsen CCJR, Hazebroek EJ, et al. Fasting induces ANGPTL4 and reduces LPL activity in human adipose tissue. Mol Metab. 2020;40:101033.","journal-title":"Mol Metab"},{"key":"2973_CR26","doi-asserted-by":"publisher","first-page":"100150","DOI":"10.1016\/j.jlr.2021.100150","volume":"62","author":"S Kersten","year":"2021","unstructured":"Kersten S. Role and mechanism of the action of angiopoietin-like protein ANGPTL4 in plasma lipid metabolism. J Lipid Res. 2021;62:100150.","journal-title":"J Lipid Res"},{"key":"2973_CR27","doi-asserted-by":"publisher","first-page":"e2214081120","DOI":"10.1073\/pnas.2214081120","volume":"120","author":"EY Zhen","year":"2023","unstructured":"Zhen EY, Chen YQ, Russell AM, et al. Angiopoietin-like protein 4\/8 complex-mediated plasmin generation leads to cleavage of the complex and restoration of LPL activity. Proc Natl Acad Sci U S A. 2023;120:e2214081120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2973_CR28","doi-asserted-by":"publisher","first-page":"100441","DOI":"10.1016\/j.jlr.2023.100441","volume":"64","author":"YQ Chen","year":"2023","unstructured":"Chen YQ, Zhen EY, Russell AM, et al. Decoding the role of angiopoietin-like protein 4\/8 complex-mediated plasmin generation in the regulation of LPL activity. J Lipid Res. 2023;64:100441.","journal-title":"J Lipid Res"},{"key":"2973_CR29","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1073\/pnas.0409564102","volume":"102","author":"X Yu","year":"2005","unstructured":"Yu X, Burgess SC, Ge H, et al. Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart. Proc Natl Acad Sci U S A. 2005;102:1767\u201372.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2973_CR30","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1161\/CIRCULATIONAHA.124.069272","volume":"151","author":"G Silbernagel","year":"2024","unstructured":"Silbernagel G, Chen YQ, Li H, et al. Associations of circulating ANGPTL3, C-terminal domain-containing ANGPTL4, and ANGPTL3\/8 and ANGPTL4\/8 complexes with LPL activity, diabetes, inflammation, and cardiovascular mortality. Circulation. 2024;151:218\u201334.","journal-title":"Circulation"},{"key":"2973_CR31","doi-asserted-by":"publisher","first-page":"120485","DOI":"10.1016\/j.atherosclerosis.2025.120485","volume":"409","author":"G Silbernagel","year":"2025","unstructured":"Silbernagel G, Higbie H, Meininger T, et al. Associations of ANGPTL proteins and complexes with progression of coronary artery calcification and coronary events. Atherosclerosis. 2025;409:120485.","journal-title":"Atherosclerosis"},{"key":"2973_CR32","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/ejhf.104","volume":"16","author":"L Koller","year":"2014","unstructured":"Koller L, Kleber M, Goliasch G, et al. C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction. Eur J Heart Fail. 2014;16:758\u201366.","journal-title":"Eur J Heart Fail"},{"key":"2973_CR33","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1093\/eurheartj\/ehm037","volume":"28","author":"WJ Paulus","year":"2007","unstructured":"Paulus WJ, Tsch\u00f6pe C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007;28:2539\u201350.","journal-title":"Eur Heart J"},{"key":"2973_CR34","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jchf.2024.02.020","volume":"12","author":"JW Ostrominski","year":"2024","unstructured":"Ostrominski JW, DeFilippis EM, Bansal K, et al. Contemporary American and European Guidelines for Heart Failure Management: JACC: Heart Failure Guideline Comparison. JACC Heart Fail. 2024;12:810\u201325.","journal-title":"JACC Heart Fail"},{"key":"2973_CR35","doi-asserted-by":"publisher","first-page":"e000034","DOI":"10.1136\/bmjdrc-2014-000034","volume":"2","author":"N Tjeerdema","year":"2014","unstructured":"Tjeerdema N, Georgiadi A, Jonker JT, et al. Inflammation increases plasma angiopoietin-like protein 4 in patients with the metabolic syndrome and type 2 diabetes. BMJ Open Diabetes Res Care. 2014;2:e000034.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2973_CR36","doi-asserted-by":"publisher","first-page":"13213","DOI":"10.1074\/jbc.M900553200","volume":"284","author":"W Yin","year":"2009","unstructured":"Yin W, Romeo S, Chang S, et al. Genetic variation in ANGPTL4 provides insights into protein processing and function. J Biol Chem. 2009;284:13213\u201322.","journal-title":"J Biol Chem"},{"key":"2973_CR37","doi-asserted-by":"publisher","first-page":"100198","DOI":"10.1016\/j.jlr.2022.100198","volume":"63","author":"D Balasubramaniam","year":"2022","unstructured":"Balasubramaniam D, Schroeder O, Russell AM, et al. An anti-ANGPTL3\/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif. J Lipid Res. 2022;63:100198.","journal-title":"J Lipid Res"},{"key":"2973_CR38","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1038\/s41591-025-03830-4","volume":"31","author":"D Gaudet","year":"2025","unstructured":"Gaudet D, Gonciarz M, Shen X, et al. Targeting the angiopoietin-like protein 3\/8 complex with a monoclonal antibody in patients with mixed hyperlipidemia: a phase 1 trial. Nat Med. 2025;31:2632\u20139.","journal-title":"Nat Med"},{"key":"2973_CR39","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","volume":"401","author":"PM Ridker","year":"2023","unstructured":"Ridker PM, Bhatt DL, Pradhan AD, et al. PROMINENT, REDUCE-IT, and STRENGTH Investigators. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomized trials. Lancet. 2023;401:1293\u2013301.","journal-title":"Lancet"},{"key":"2973_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1161\/CIRCULATIONAHA.123.066213","volume":"149","author":"PM Ridker","year":"2024","unstructured":"Ridker PM, Lei L, Louie MJ, et al. Inflammation and cholesterol as predictors of cardiovascular events among 13970 contemporary high-risk patients with statin intolerance. Circulation. 2024;149:28\u201335.","journal-title":"Circulation"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-026-02973-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02973-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02973-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:37:43Z","timestamp":1782776263000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12944-026-02973-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2973"],"URL":"https:\/\/doi.org\/10.1186\/s12944-026-02973-8","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The LURIC study complied with the Declaration of Helsinki and was approved by the Ethics Committee of the \u2018Landes\u00e4rztekammer Rheinland-Pfalz\u2019 (Mainz, Germany). Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"H.L., D.L., Y.Q.C., E.Z., Y.W., and R.J.K. are Eli Lilly and Company employees and own Lilly stock. G.S. has received research funding from Numares AG, Sanofi, Bayer, and Eli Lilly, consulting fees from Sanofi, honoraria from Sanofi and Daiichi-Sankyo, meeting travel expenses from Bayer, Amgen, Daiichi-Sankyo, and research materials from Eli Lilly. H.S. has received research grants and support from Abbott Diagnostics and Amgen and honoraria from Amgen and Sanofi. M.E.K. has received employment from SYNLAB Holding, Deutschland. W.M. has received grants from Siemens, AstraZeneca, Bayer Vital, Bestbion Dx, Boehringer Ingelheim, Immundiagnostik, Merck Chemicals, and Olink, grants and personal fees from Aegerion, Amgen, Sanofi, Amryt Pharma, BASF, Abbott Diagnostics, Numares AG, Berlin-Chemie, Akzea Therapeutics, and Novartis, personal fees from Vifor Pharma, and employment from SYNLAB Holding Deutschland. The other authors declare no disclosures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}